Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 316 AL 330

Putamen Structural-Functional Decoupling as an Early-Stage Candidate Imaging Marker for Motor Severity in Spinocerebellar Ataxia Type 3

Ou L, Yang J, Shi L, Wang X, Ou P, Huang Y, Chen H, Li C, Fan R, Wang B, Hsu Y, Ma G, Chen W, Wang J, Long Z, Liu C.

Mov Disord. 2026 Oct;41(10):2650-2661. doi: 10.1002/mds.70402. Epub 2026 Jun 29.

Beyond Parkinson's: The Challenge of Diagnosing Multiple System Atrophy-C

Vikhe VB, Chakraborty A, Lapsiwala V, Shaik MH, Faruqi AA.

Ann Afr Med. 2026 Oct 1;25(Suppl 3):S645-S648. doi: 10.4103/aam.aam_294_26. Epub 2026 Jun 30.

Insights into X-linked Dystonia-Parkinsonism and Spinocerebellar Ataxia type 36 Through the Lens of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia

Patel M, Das S, Kumari AP, Kumar A.

Mol Neurobiol. 2026 Sep 26;63(1):926. doi: 10.1007/s12035-026-06209-9.

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review

Gowda N, Harish S.

Neurogenetics. 2026 Oct 2;27(1):78. doi: 10.1007/s10048-026-00946-8.

Parkinsonism with Reduced Striatal Uptake on DAT-SPECT in a Patient Harboring a Novel KCND3 Variant

Katanazaka K, Takata M, Kanai C, Matsumoto S, Matoba K, Otani M, Koto S, Sekiguchi K, Takahashi Y, Mizusawa H, Chihara N.

Cerebellum. 2026 Oct 7;25(5):153. doi: 10.1007/s12311-026-02092-1.

Management of fragile X-associated tremor ataxia syndrome: a review for clinicians

Hall DA, González DA, Klusek J, Todd PK, O'Keefe JA, Maltman N, Montanaro FAM, Protic D, Scorr L, Malik R, Turcano P, Meyers MS, Seritan A.

Front Neurol. 2026 Oct 7;17:1870779. doi: 10.3389/fneur.2026.1870779. eCollection 2026.

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

He Z, Zeng J, Wang G, Li Y, Zhang F.

MedComm (2020). 2026 Oct 23;7(11):e71090. doi: 10.1002/mco2.71090. eCollection 2026 Nov.

Pseudodominant inheritance in paraplegin (SPG7)-associated CPEO-ataxia syndrome

Liu W, Geara S, Rowe S, Sue CM.

Neurogenetics. 2026 Oct 28;27(1):84. doi: 10.1007/s10048-026-00955-7.

From bench to beside: luteolin's therapeutic promise in neurological disorders

Zhu W, Yuan N, Tang M, She K, Chen M, Huang M, Feng R, Ma Q, Chen J.

Chin J Nat Med. 2026 Oct;24(10):1153-1162. doi: 10.1016/S1875-5364(26)61211-3.

Immunosenescence as a modifiable driver of neurodegenerative diseases: Pathways and multidimensional emerging strategies for Alzheimer's and Parkinson's diseases

Zhao J, Qu L, Guan H, Che H, Shi F, Yang Y.

Neurotherapeutics. 2026 Oct;23(6):e01096. doi: 10.1016/j.neurot.2026.e01096. Epub 2026 Oct 12.

The gut-brain axis in Alzheimer's and Parkinson's diseases: a comparative perspective

Upadhyay R, C C, Kar S, Sathyamoorthy S, Pitchaimuthu X, Sevanan M.

Front Microbiomes. 2026 Sep 30;5:1942228. doi: 10.3389/frmbi.2026.1942228. eCollection 2026.

Gingipains as macromolecular mediators at the periodontal-brain interface: Mechanistic, diagnostic, and therapeutic evidence in Alzheimer's and Parkinson's diseases

Dhar I, Gupta S, Mishra R, Dadhich A.

Int J Biol Macromol. 2026 Oct;377:153320. doi: 10.1016/j.ijbiomac.2026.153320. Epub 2026 Jul 2.

Safety and tolerability of intranasal insulin in Parkinson's disease

Johnson JC, Kashyap B, Gustafson SK, O'Brien M, Frey WH 2nd, Svitak AL, Hanson LR.

Front Neurol. 2026 Sep 9;17:1875165. doi: 10.3389/fneur.2026.1875165. eCollection 2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias